Kestra Medical Technologies (NASDAQ:KMTS) Trading Down 8.6% - Time to Sell?

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS - Get Free Report) dropped 8.6% on Monday . The company traded as low as $14.26 and last traded at $14.33. Approximately 296,996 shares changed hands during mid-day trading, an increase of 19% from the average daily volume of 249,120 shares. The stock had previously closed at $15.67.

Analyst Upgrades and Downgrades

KMTS has been the subject of a number of recent analyst reports. Stifel Nicolaus initiated coverage on Kestra Medical Technologies in a research note on Monday, March 31st. They issued a "buy" rating and a $28.00 price objective for the company. The Goldman Sachs Group dropped their price target on Kestra Medical Technologies from $24.00 to $23.00 and set a "neutral" rating for the company in a research note on Wednesday, April 16th. Wolfe Research initiated coverage on Kestra Medical Technologies in a research note on Monday, March 31st. They set an "outperform" rating and a $29.00 price target for the company. Wells Fargo & Company initiated coverage on Kestra Medical Technologies in a research note on Monday, March 31st. They set an "overweight" rating and a $28.00 price target for the company. Finally, Piper Sandler initiated coverage on Kestra Medical Technologies in a research note on Monday, March 31st. They set an "overweight" rating and a $27.00 price target for the company. One analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $27.50.

Kestra Medical Technologies Price Performance

The firm's 50 day moving average is $20.21.

Kestra Medical Technologies (NASDAQ:KMTS - Get Free Report) last posted its quarterly earnings data on Monday, April 14th. The company reported ($1.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.64) by ($0.61). During the same quarter last year, the company earned ($1.18) earnings per share.

Institutional Investors Weigh In On Kestra Medical Technologies

Several hedge funds and other institutional investors have recently modified their holdings of KMTS. Yu Fan purchased a new stake in shares of Kestra Medical Technologies in the first quarter worth approximately $56,880,000. T. Rowe Price Investment Management Inc. purchased a new position in Kestra Medical Technologies during the 1st quarter worth $56,613,000. Omega Fund Management LLC purchased a new position in Kestra Medical Technologies during the 1st quarter worth $44,754,000. Alliancebernstein L.P. purchased a new position in Kestra Medical Technologies during the 1st quarter worth $29,500,000. Finally, Brown Advisory Inc. purchased a new position in Kestra Medical Technologies during the 1st quarter worth $13,716,000.

About Kestra Medical Technologies

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.